Global Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 124

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.

The Global Info Research report includes an overview of the development of the Antisense Oligonucleotides industry chain, the market status of Hospitals (RNA Antisense Oligonucleotides, DNA Antisense Oligonucleotides), Clinic (RNA Antisense Oligonucleotides, DNA Antisense Oligonucleotides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antisense Oligonucleotides.

Regionally, the report analyzes the Antisense Oligonucleotides markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antisense Oligonucleotides market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Antisense Oligonucleotides market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antisense Oligonucleotides industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., RNA Antisense Oligonucleotides, DNA Antisense Oligonucleotides).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antisense Oligonucleotides market.

Regional Analysis: The report involves examining the Antisense Oligonucleotides market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antisense Oligonucleotides market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Antisense Oligonucleotides:
Company Analysis: Report covers individual Antisense Oligonucleotides players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antisense Oligonucleotides This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinic).

Technology Analysis: Report covers specific technologies relevant to Antisense Oligonucleotides. It assesses the current state, advancements, and potential future developments in Antisense Oligonucleotides areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antisense Oligonucleotides market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Antisense Oligonucleotides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
RNA Antisense Oligonucleotides
DNA Antisense Oligonucleotides

Market segment by Application
Hospitals
Clinic
Others

Market segment by players, this report covers
Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline
Geron
ICO Therapeutics
Marina Biotech
RXi Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antisense Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antisense Oligonucleotides, with revenue, gross margin and global market share of Antisense Oligonucleotides from 2019 to 2024.
Chapter 3, the Antisense Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antisense Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides.
Chapter 13, to describe Antisense Oligonucleotides research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antisense Oligonucleotides
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Antisense Oligonucleotides by Type
        1.3.1 Overview: Global Antisense Oligonucleotides Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2023
        1.3.3 RNA Antisense Oligonucleotides
        1.3.4 DNA Antisense Oligonucleotides
    1.4 Global Antisense Oligonucleotides Market by Application
        1.4.1 Overview: Global Antisense Oligonucleotides Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Antisense Oligonucleotides Market Size & Forecast
    1.6 Global Antisense Oligonucleotides Market Size and Forecast by Region
        1.6.1 Global Antisense Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Antisense Oligonucleotides Market Size by Region, (2019-2030)
        1.6.3 North America Antisense Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.4 Europe Antisense Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Antisense Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.6 South America Antisense Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Antisense Oligonucleotides Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Ionis Pharmaceuticals
        2.1.1 Ionis Pharmaceuticals Details
        2.1.2 Ionis Pharmaceuticals Major Business
        2.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans
    2.2 Sarepta Therapeutics
        2.2.1 Sarepta Therapeutics Details
        2.2.2 Sarepta Therapeutics Major Business
        2.2.3 Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
        2.2.4 Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.3 Biogen
        2.3.1 Biogen Details
        2.3.2 Biogen Major Business
        2.3.3 Biogen Antisense Oligonucleotides Product and Solutions
        2.3.4 Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Biogen Recent Developments and Future Plans
    2.4 Alnylam Pharmaceuticals
        2.4.1 Alnylam Pharmaceuticals Details
        2.4.2 Alnylam Pharmaceuticals Major Business
        2.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.4.4 Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.5 Antisense Therapeutics
        2.5.1 Antisense Therapeutics Details
        2.5.2 Antisense Therapeutics Major Business
        2.5.3 Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
        2.5.4 Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Antisense Therapeutics Recent Developments and Future Plans
    2.6 Isarna Therapeutics
        2.6.1 Isarna Therapeutics Details
        2.6.2 Isarna Therapeutics Major Business
        2.6.3 Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
        2.6.4 Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Isarna Therapeutics Recent Developments and Future Plans
    2.7 Arrowhead Pharmaceuticals
        2.7.1 Arrowhead Pharmaceuticals Details
        2.7.2 Arrowhead Pharmaceuticals Major Business
        2.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.7.4 Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Arrowhead Pharmaceuticals Recent Developments and Future Plans
    2.8 Atlantic Pharmaceuticals
        2.8.1 Atlantic Pharmaceuticals Details
        2.8.2 Atlantic Pharmaceuticals Major Business
        2.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.8.4 Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Atlantic Pharmaceuticals Recent Developments and Future Plans
    2.9 Enzon Pharmaceuticals
        2.9.1 Enzon Pharmaceuticals Details
        2.9.2 Enzon Pharmaceuticals Major Business
        2.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.9.4 Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Enzon Pharmaceuticals Recent Developments and Future Plans
    2.10 Bio-Path Holdings
        2.10.1 Bio-Path Holdings Details
        2.10.2 Bio-Path Holdings Major Business
        2.10.3 Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
        2.10.4 Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Bio-Path Holdings Recent Developments and Future Plans
    2.11 GlaxoSmithKline
        2.11.1 GlaxoSmithKline Details
        2.11.2 GlaxoSmithKline Major Business
        2.11.3 GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
        2.11.4 GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 GlaxoSmithKline Recent Developments and Future Plans
    2.12 Geron
        2.12.1 Geron Details
        2.12.2 Geron Major Business
        2.12.3 Geron Antisense Oligonucleotides Product and Solutions
        2.12.4 Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Geron Recent Developments and Future Plans
    2.13 ICO Therapeutics
        2.13.1 ICO Therapeutics Details
        2.13.2 ICO Therapeutics Major Business
        2.13.3 ICO Therapeutics Antisense Oligonucleotides Product and Solutions
        2.13.4 ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 ICO Therapeutics Recent Developments and Future Plans
    2.14 Marina Biotech
        2.14.1 Marina Biotech Details
        2.14.2 Marina Biotech Major Business
        2.14.3 Marina Biotech Antisense Oligonucleotides Product and Solutions
        2.14.4 Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Marina Biotech Recent Developments and Future Plans
    2.15 RXi Pharmaceuticals
        2.15.1 RXi Pharmaceuticals Details
        2.15.2 RXi Pharmaceuticals Major Business
        2.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
        2.15.4 RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 RXi Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Antisense Oligonucleotides Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Antisense Oligonucleotides by Company Revenue
        3.2.2 Top 3 Antisense Oligonucleotides Players Market Share in 2023
        3.2.3 Top 6 Antisense Oligonucleotides Players Market Share in 2023
    3.3 Antisense Oligonucleotides Market: Overall Company Footprint Analysis
        3.3.1 Antisense Oligonucleotides Market: Region Footprint
        3.3.2 Antisense Oligonucleotides Market: Company Product Type Footprint
        3.3.3 Antisense Oligonucleotides Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Antisense Oligonucleotides Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Antisense Oligonucleotides Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2024)
    5.2 Global Antisense Oligonucleotides Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Antisense Oligonucleotides Consumption Value by Type (2019-2030)
    6.2 North America Antisense Oligonucleotides Consumption Value by Application (2019-2030)
    6.3 North America Antisense Oligonucleotides Market Size by Country
        6.3.1 North America Antisense Oligonucleotides Consumption Value by Country (2019-2030)
        6.3.2 United States Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.3 Canada Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.4 Mexico Antisense Oligonucleotides Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Antisense Oligonucleotides Consumption Value by Type (2019-2030)
    7.2 Europe Antisense Oligonucleotides Consumption Value by Application (2019-2030)
    7.3 Europe Antisense Oligonucleotides Market Size by Country
        7.3.1 Europe Antisense Oligonucleotides Consumption Value by Country (2019-2030)
        7.3.2 Germany Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.3 France Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.5 Russia Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.6 Italy Antisense Oligonucleotides Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Antisense Oligonucleotides Market Size by Region
        8.3.1 Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2019-2030)
        8.3.2 China Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.3 Japan Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.4 South Korea Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.5 India Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.7 Australia Antisense Oligonucleotides Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Antisense Oligonucleotides Consumption Value by Type (2019-2030)
    9.2 South America Antisense Oligonucleotides Consumption Value by Application (2019-2030)
    9.3 South America Antisense Oligonucleotides Market Size by Country
        9.3.1 South America Antisense Oligonucleotides Consumption Value by Country (2019-2030)
        9.3.2 Brazil Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        9.3.3 Argentina Antisense Oligonucleotides Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Antisense Oligonucleotides Market Size by Country
        10.3.1 Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2019-2030)
        10.3.2 Turkey Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Antisense Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.4 UAE Antisense Oligonucleotides Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Antisense Oligonucleotides Market Drivers
    11.2 Antisense Oligonucleotides Market Restraints
    11.3 Antisense Oligonucleotides Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Antisense Oligonucleotides Industry Chain
    12.2 Antisense Oligonucleotides Upstream Analysis
    12.3 Antisense Oligonucleotides Midstream Analysis
    12.4 Antisense Oligonucleotides Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Antisense Oligonucleotides Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Antisense Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Antisense Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Ionis Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 6. Ionis Pharmaceuticals Major Business
    Table 7. Ionis Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 8. Ionis Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Ionis Pharmaceuticals Recent Developments and Future Plans
    Table 10. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 11. Sarepta Therapeutics Major Business
    Table 12. Sarepta Therapeutics Antisense Oligonucleotides Product and Solutions
    Table 13. Sarepta Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Sarepta Therapeutics Recent Developments and Future Plans
    Table 15. Biogen Company Information, Head Office, and Major Competitors
    Table 16. Biogen Major Business
    Table 17. Biogen Antisense Oligonucleotides Product and Solutions
    Table 18. Biogen Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Biogen Recent Developments and Future Plans
    Table 20. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 21. Alnylam Pharmaceuticals Major Business
    Table 22. Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 23. Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Table 25. Antisense Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. Antisense Therapeutics Major Business
    Table 27. Antisense Therapeutics Antisense Oligonucleotides Product and Solutions
    Table 28. Antisense Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Antisense Therapeutics Recent Developments and Future Plans
    Table 30. Isarna Therapeutics Company Information, Head Office, and Major Competitors
    Table 31. Isarna Therapeutics Major Business
    Table 32. Isarna Therapeutics Antisense Oligonucleotides Product and Solutions
    Table 33. Isarna Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Isarna Therapeutics Recent Developments and Future Plans
    Table 35. Arrowhead Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 36. Arrowhead Pharmaceuticals Major Business
    Table 37. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 38. Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Arrowhead Pharmaceuticals Recent Developments and Future Plans
    Table 40. Atlantic Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Atlantic Pharmaceuticals Major Business
    Table 42. Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 43. Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Atlantic Pharmaceuticals Recent Developments and Future Plans
    Table 45. Enzon Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 46. Enzon Pharmaceuticals Major Business
    Table 47. Enzon Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 48. Enzon Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Enzon Pharmaceuticals Recent Developments and Future Plans
    Table 50. Bio-Path Holdings Company Information, Head Office, and Major Competitors
    Table 51. Bio-Path Holdings Major Business
    Table 52. Bio-Path Holdings Antisense Oligonucleotides Product and Solutions
    Table 53. Bio-Path Holdings Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Bio-Path Holdings Recent Developments and Future Plans
    Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 56. GlaxoSmithKline Major Business
    Table 57. GlaxoSmithKline Antisense Oligonucleotides Product and Solutions
    Table 58. GlaxoSmithKline Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. GlaxoSmithKline Recent Developments and Future Plans
    Table 60. Geron Company Information, Head Office, and Major Competitors
    Table 61. Geron Major Business
    Table 62. Geron Antisense Oligonucleotides Product and Solutions
    Table 63. Geron Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Geron Recent Developments and Future Plans
    Table 65. ICO Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. ICO Therapeutics Major Business
    Table 67. ICO Therapeutics Antisense Oligonucleotides Product and Solutions
    Table 68. ICO Therapeutics Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. ICO Therapeutics Recent Developments and Future Plans
    Table 70. Marina Biotech Company Information, Head Office, and Major Competitors
    Table 71. Marina Biotech Major Business
    Table 72. Marina Biotech Antisense Oligonucleotides Product and Solutions
    Table 73. Marina Biotech Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Marina Biotech Recent Developments and Future Plans
    Table 75. RXi Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 76. RXi Pharmaceuticals Major Business
    Table 77. RXi Pharmaceuticals Antisense Oligonucleotides Product and Solutions
    Table 78. RXi Pharmaceuticals Antisense Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 79. RXi Pharmaceuticals Recent Developments and Future Plans
    Table 80. Global Antisense Oligonucleotides Revenue (USD Million) by Players (2019-2024)
    Table 81. Global Antisense Oligonucleotides Revenue Share by Players (2019-2024)
    Table 82. Breakdown of Antisense Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Antisense Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 84. Head Office of Key Antisense Oligonucleotides Players
    Table 85. Antisense Oligonucleotides Market: Company Product Type Footprint
    Table 86. Antisense Oligonucleotides Market: Company Product Application Footprint
    Table 87. Antisense Oligonucleotides New Market Entrants and Barriers to Market Entry
    Table 88. Antisense Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Antisense Oligonucleotides Consumption Value (USD Million) by Type (2019-2024)
    Table 90. Global Antisense Oligonucleotides Consumption Value Share by Type (2019-2024)
    Table 91. Global Antisense Oligonucleotides Consumption Value Forecast by Type (2025-2030)
    Table 92. Global Antisense Oligonucleotides Consumption Value by Application (2019-2024)
    Table 93. Global Antisense Oligonucleotides Consumption Value Forecast by Application (2025-2030)
    Table 94. North America Antisense Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 95. North America Antisense Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 96. North America Antisense Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 97. North America Antisense Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 98. North America Antisense Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 99. North America Antisense Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 100. Europe Antisense Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 101. Europe Antisense Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 102. Europe Antisense Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 103. Europe Antisense Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 104. Europe Antisense Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 105. Europe Antisense Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 106. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 107. Asia-Pacific Antisense Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 108. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 109. Asia-Pacific Antisense Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 110. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 111. Asia-Pacific Antisense Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 112. South America Antisense Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 113. South America Antisense Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 114. South America Antisense Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 115. South America Antisense Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 116. South America Antisense Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 117. South America Antisense Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 118. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Antisense Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 120. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 121. Middle East & Africa Antisense Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 122. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 123. Middle East & Africa Antisense Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 124. Antisense Oligonucleotides Raw Material
    Table 125. Key Suppliers of Antisense Oligonucleotides Raw Materials
List of Figures
    Figure 1. Antisense Oligonucleotides Picture
    Figure 2. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Antisense Oligonucleotides Consumption Value Market Share by Type in 2023
    Figure 4. RNA Antisense Oligonucleotides
    Figure 5. DNA Antisense Oligonucleotides
    Figure 6. Global Antisense Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Antisense Oligonucleotides Consumption Value Market Share by Application in 2023
    Figure 8. Hospitals Picture
    Figure 9. Clinic Picture
    Figure 10. Others Picture
    Figure 11. Global Antisense Oligonucleotides Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Antisense Oligonucleotides Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Market Antisense Oligonucleotides Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 14. Global Antisense Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 15. Global Antisense Oligonucleotides Consumption Value Market Share by Region in 2023
    Figure 16. North America Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 17. Europe Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 18. Asia-Pacific Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 19. South America Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 20. Middle East and Africa Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 21. Global Antisense Oligonucleotides Revenue Share by Players in 2023
    Figure 22. Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 23. Global Top 3 Players Antisense Oligonucleotides Market Share in 2023
    Figure 24. Global Top 6 Players Antisense Oligonucleotides Market Share in 2023
    Figure 25. Global Antisense Oligonucleotides Consumption Value Share by Type (2019-2024)
    Figure 26. Global Antisense Oligonucleotides Market Share Forecast by Type (2025-2030)
    Figure 27. Global Antisense Oligonucleotides Consumption Value Share by Application (2019-2024)
    Figure 28. Global Antisense Oligonucleotides Market Share Forecast by Application (2025-2030)
    Figure 29. North America Antisense Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 30. North America Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 31. North America Antisense Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 32. United States Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 33. Canada Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 34. Mexico Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 35. Europe Antisense Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 36. Europe Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 37. Europe Antisense Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 38. Germany Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 39. France Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 40. United Kingdom Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 41. Russia Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 42. Italy Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 43. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 44. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 45. Asia-Pacific Antisense Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 46. China Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 47. Japan Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 48. South Korea Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 49. India Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 50. Southeast Asia Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 51. Australia Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 52. South America Antisense Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 53. South America Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 54. South America Antisense Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 55. Brazil Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 56. Argentina Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 57. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 58. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 59. Middle East and Africa Antisense Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 60. Turkey Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 61. Saudi Arabia Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 62. UAE Antisense Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 63. Antisense Oligonucleotides Market Drivers
    Figure 64. Antisense Oligonucleotides Market Restraints
    Figure 65. Antisense Oligonucleotides Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides in 2023
    Figure 68. Manufacturing Process Analysis of Antisense Oligonucleotides
    Figure 69. Antisense Oligonucleotides Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis Pharmaceuticals
Sarepta Therapeutics
Biogen
Alnylam Pharmaceuticals
Antisense Therapeutics
Isarna Therapeutics
Arrowhead Pharmaceuticals
Atlantic Pharmaceuticals
Enzon Pharmaceuticals
Bio-Path Holdings
GlaxoSmithKline
Geron
ICO Therapeutics
Marina Biotech
RXi Pharmaceuticals

Related Reports

Global Antisense Oligonucleotides Supply, Demand and Key Producers, 2023-2029

Global Antisense Oligonucleotides Supply, Demand and Key Producers, 2023-2029

date 22 Feb 2023

date Medical Care

The global Antisense Oligonucleotides market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Antisense Oligonucleotides (ASO) Drug

Antisense oligonucleotides (ASO) Drug and siRNA Drug

Antisense Oligonucleotides

CNS Specific Antisense Oligonucleotides

Antisense Oligonucleotides-based Therapeutics

Antisense Oligonucleotides (ASO) Therapy

Antisense Oligonucleotides (ASOs) Drugs

Antisense Oligonucleotides Drugs for ATTR

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>